IL75671A0 - Method and apparatus for pulsed administration of growth promoting agents - Google Patents

Method and apparatus for pulsed administration of growth promoting agents

Info

Publication number
IL75671A0
IL75671A0 IL75671A IL7567185A IL75671A0 IL 75671 A0 IL75671 A0 IL 75671A0 IL 75671 A IL75671 A IL 75671A IL 7567185 A IL7567185 A IL 7567185A IL 75671 A0 IL75671 A0 IL 75671A0
Authority
IL
Israel
Prior art keywords
growth promoting
promoting agents
pulsed administration
pulsed
administration
Prior art date
Application number
IL75671A
Other languages
English (en)
Original Assignee
Linkie Daniel M
Thorner Michael O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linkie Daniel M, Thorner Michael O filed Critical Linkie Daniel M
Publication of IL75671A0 publication Critical patent/IL75671A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL75671A 1984-06-29 1985-06-28 Method and apparatus for pulsed administration of growth promoting agents IL75671A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/626,400 US4747825A (en) 1984-06-29 1984-06-29 Apparatus and methodology for pulsed administration of growth promoting agents

Publications (1)

Publication Number Publication Date
IL75671A0 true IL75671A0 (en) 1985-10-31

Family

ID=24510242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75671A IL75671A0 (en) 1984-06-29 1985-06-28 Method and apparatus for pulsed administration of growth promoting agents

Country Status (16)

Country Link
US (1) US4747825A (fr)
EP (1) EP0190199A4 (fr)
JP (1) JPS61502519A (fr)
AU (1) AU4605385A (fr)
BE (1) BE902783A (fr)
BR (1) BR8506785A (fr)
DK (1) DK294685A (fr)
FI (1) FI852516L (fr)
IL (1) IL75671A0 (fr)
MW (1) MW686A1 (fr)
NO (1) NO852603L (fr)
OA (1) OA08214A (fr)
PT (1) PT80738B (fr)
RO (1) RO95012A (fr)
WO (1) WO1986000233A1 (fr)
ZA (1) ZA854916B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
US5065748A (en) * 1989-11-14 1991-11-19 University Of South Florida Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone
US5065747A (en) * 1989-11-21 1991-11-19 University Of South Florida Method for improving the accuracy of diagnosis of growth hormone deficiency
US5428013A (en) * 1991-01-04 1995-06-27 Mugica; Jesus D. Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
WO1995011699A1 (fr) * 1993-10-29 1995-05-04 The Trustees Of Boston University Compositions physiologiquement stables d'acide butyrique, de sels et de derives d'acide butyrique, utilisees comme agents antineoplasiques
EP0800405A4 (fr) * 1994-12-19 1998-11-11 Beth Israel Hospital Administration en continu de faibles doses d'hormone parathyro dienne ou de son agoniste
US5939456A (en) * 1996-07-26 1999-08-17 Perrine; Susan P. Pulsed administration of compositions for the treatment of blood disorders
EP1886677A1 (fr) 1996-07-26 2008-02-13 Susan P. Perrine Composition comprenant un agent d'induction et agent antiviral pour le traitement de maladies sanguines, virales et cellulaires
US6403647B1 (en) 1996-07-26 2002-06-11 Susan P. Perrine Pulsed administration of compositions for the treatment of blood disorders
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
AU774861B2 (en) * 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2010105112A1 (fr) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Détection d'acides gras à chaîne courte dans des échantillons biologiques
US20130017188A1 (en) 2009-07-31 2013-01-17 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (fr) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Procédés et régimes à faible dose pour traiter des troubles des globules rouges
WO2011113013A2 (fr) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Procédés et compositions pour le traitement d'états viraux ou induits par des virus
EP2670426B1 (fr) 2011-01-31 2017-05-10 The General Hospital Corporation Molécules trail multimodales et leurs utilisations en thérapies cellulaires
WO2012129237A2 (fr) 2011-03-20 2012-09-27 Trustees Of Boston University Agent thérapeutique utilisable en vue du traitement de l'emphysème et de la maladie pulmonaire obstructive chronique
WO2012151474A2 (fr) 2011-05-04 2012-11-08 Trustees Of Boston University Stimulation de la force proton motrice pour potentialiser des antibiotiques aminoglycosides contre bactéries persistantes
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2766041B1 (fr) 2011-10-12 2018-12-05 Children's Medical Center Corporation Compositions combinatoires et méthodes de traitement d'hémoglobinopathies
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
WO2013082275A1 (fr) 2011-11-30 2013-06-06 Trustees Of Boston College Inhibiteurs de phosphodiestérases 11 (pde11) et procédés d'utilisation pour augmenter la production de cortisol
EP3698809A1 (fr) 2012-07-31 2020-08-26 The Brigham & Women's Hospital, Inc. Modulation de la réponse immunitaire avec moyen se liant à tim-3 et ceacam-1
WO2014035474A1 (fr) 2012-08-30 2014-03-06 The General Hospital Corporation Compositions et méthodes de traitement du cancer
BR112015008118A2 (pt) 2012-10-12 2017-12-05 Brigham & Womens Hospital Inc reforço da resposta imune
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
WO2015027146A1 (fr) 2013-08-22 2015-02-26 The General Hospital Corporation Inhibiteurs de la 12/15-lipoxygénase- humaine
EP3038625A4 (fr) 2013-08-29 2017-08-23 Trustees of Boston University Produits métaboliques intermédiaires pour potentialiser des antibiotiques aminoglycosides dans des infections bactériennes
WO2015081073A2 (fr) 2013-11-26 2015-06-04 The Brigham And Women's Hospital, Inc. Compositions et procédés pour moduler une réponse immunitaire
AU2014362307A1 (en) 2013-12-11 2016-06-30 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
US20170107300A1 (en) 2014-03-21 2017-04-20 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
EP3804745A1 (fr) 2014-04-25 2021-04-14 The Brigham and Women's Hospital, Inc. Procédés de manipulation de l'alpha-f toprotéine (afp)
US20170045528A1 (en) 2014-04-25 2017-02-16 The Brigham And Women's Hospital, Inc. Compositions and methods for treating subjects with immune-mediated diseases
EP3194446B1 (fr) 2014-09-18 2022-10-26 Cedars-Sinai Medical Center Compositions et procédés de traitement de la fibrose
EP3244926A4 (fr) 2015-01-14 2018-06-27 The Brigham and Women's Hospital, Inc. Traitement du cancer avec des anticorps monoclonaux anti-lap
CN114366802A (zh) 2015-04-22 2022-04-19 西达-赛奈医疗中心 用于治疗2型糖尿病的肠内递送的苦味寡肽
WO2016196664A1 (fr) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Procédés et utilisation de composés qui se lient à rela de nf-kb
US20180185345A1 (en) 2015-06-19 2018-07-05 Trustees Of Boston University Methods and compositions for treating herpesvirus induced conditions
RU2018107227A (ru) 2015-07-28 2019-08-28 Виоме Терапьютикс Лимитед Терапевтические и профилактические антибактериальные средства
WO2017058828A1 (fr) 2015-09-28 2017-04-06 Children's Hospital Los Angeles Méthodes de traitement de maladies à médiation par les macrophages pro-inflammatoires positifs à l'erbb4
US20190255107A1 (en) 2015-10-09 2019-08-22 The Brigham And Women's Hospital, Inc. Modulation of novel immune checkpoint targets
US20200016202A1 (en) 2016-10-07 2020-01-16 The Brigham And Women's Hospital, Inc. Modulation of novel immune checkpoint targets
AU2019217207A1 (en) 2018-02-12 2020-08-27 Diabetes-Free, Inc. Improved antagonistic anti-human CD40 monoclonal antibodies
WO2020102454A1 (fr) 2018-11-13 2020-05-22 Regents Of The University Of Minnesota Peptides ciblant le cd40 et leurs utilisations
KR20220034736A (ko) 2019-05-31 2022-03-18 비락타 서브시디어리 인크. 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3498228A (en) * 1967-05-01 1970-03-03 Charles A Blumle Portable infusion pump
US3559644A (en) * 1967-12-14 1971-02-02 Robert F Shaw Liquid infusion apparatus
US3809871A (en) * 1972-12-01 1974-05-07 Nasa Programmable physiological infusion
US4273122A (en) * 1976-11-12 1981-06-16 Whitney Douglass G Self contained powered injection system
US4313439A (en) * 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
DE3015777A1 (de) * 1980-04-24 1981-10-29 Ferring Arzneimittel Gmbh, 2300 Kiel Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln
US4306553A (en) * 1980-07-22 1981-12-22 The Regents Of The University Of Minnesota Method of maintaining the fluidity of hormone solutions for parenteral administration
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
US4529595A (en) * 1983-01-13 1985-07-16 The Salk Institute For Biological Studies GRF Analogs

Also Published As

Publication number Publication date
ZA854916B (en) 1986-02-26
PT80738B (en) 1986-12-11
OA08214A (en) 1987-10-30
AU4605385A (en) 1986-01-24
BR8506785A (pt) 1986-11-25
DK294685A (da) 1985-12-30
FI852516L (fi) 1985-12-30
BE902783A (fr) 1985-10-16
FI852516A0 (fi) 1985-06-26
PT80738A (en) 1985-07-01
JPS61502519A (ja) 1986-11-06
DK294685D0 (da) 1985-06-28
US4747825A (en) 1988-05-31
MW686A1 (en) 1987-03-11
WO1986000233A1 (fr) 1986-01-16
EP0190199A1 (fr) 1986-08-13
NO852603L (no) 1985-12-30
RO95012A (fr) 1988-09-15
EP0190199A4 (fr) 1987-12-01

Similar Documents

Publication Publication Date Title
IL75671A0 (en) Method and apparatus for pulsed administration of growth promoting agents
EP0281102A3 (en) Method and apparatus for specification of cummunication method and apparatus for specification of cummunication parameters parameters
EP0151526A3 (en) Method of and apparatus for soil stabilisation
PL264908A1 (en) Agent for and method of controlling plant growth
IL79223A0 (en) Method and apparatus for ophthalmological surgery
EP0219077A3 (en) Method of and apparatus for making bread
EP0207648A3 (en) Method and apparatus for ophthalmological surgery
EP0235699A3 (en) Steam-shower apparatus and method of using same steam-shower apparatus and method of using same
EP0218427A3 (en) Method and apparatus for ophthalmological surgery
BG50035A3 (en) Method for preparing of human leucocites and gamma- interferons
GB2187984B (en) Method of and apparatus for casting
GB8529946D0 (en) Method and apparatus for growing cdxhg1-xte
GB2164677B (en) Method and apparatus for treatment of a structure
JPS6463546A (en) Composition and method for accelerating growth of animal
GB2183063B (en) Method of and system for performing time setting
EP0305220A3 (en) Method of tillage and implement for same
CS283587A1 (en) Method of treatment of surfaces of aluminiumtoytrit perovskit monocrystal and aluminiumtoytrit granate for low-energy beta ratiation
BG41842A1 (en) Method for simultaneous treatment of femuro- thibial and femuro- patelaric artrose
PL247081A1 (en) Method of and apparatus for cultivation of champignons
BG40573A1 (en) Method for simultaneous preparing of acetoxymethyllongipholene and isolongipholene
GB8919258D0 (en) Improved method and apparatus of land improvement
BG44272A1 (en) Unsaturated derivatives of benzantron and method for their preparation
BG40731A1 (en) Derivatives of 3- cynamoyl- 2h- 1- benzopyran- 2- on and method for their preparing
PL262729A1 (en) Apparatus and method for drip-watering of plants
BG43254A1 (en) Derivatives of 1- benzhydrylpiperazine and method for their preparation